mRESVIA won approval based on the Phase III ConquerRSV trial, a global study of around 37,000 adults aged 60 or older in 22 countries, in which it displayed an efficacy rate of 83.7% against RSV lower respiratory tract disease
Knop, MD, PhD, professor of endocrinology and director of the Center for Clinical Metabolic Research at Gentofte Hospital at the University of Copenhagen, explained how these results might affect patient care going forward and what additional research is needed
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
BASICY SUMMARY : LIPO GLUTA NIAC CEN 13.7% (Glutathione 1,000ppm, Niacinamide 1,000ppm, Centella Asiatica Extract 13.5%), combined with Centella 3x Complex CENTELLA 3X COMPLEX: The following components of Madecassic Acid, Asiaticoside, and Asiatic Acid come from a leaf called Centella asiatica
However, if you are looking to target a specific area, here is how to decide
